{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:39:27Z","timestamp":1790264367486,"version":"4.1.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T00:00:00Z","timestamp":1378425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00198-013-2480-9","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T12:32:20Z","timestamp":1378384340000},"page":"423-439","source":"Crossref","is-referenced-by-count":74,"title":["Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass"],"prefix":"10.1007","volume":"25","author":[{"given":"M. P.","family":"Hage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"El-Hajj Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"2480_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA 307:491\u2013497","journal-title":"JAMA"},{"key":"2480_CR2","unstructured":"(2008) Obesity and Overweight. World Health Organization. http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en"},{"key":"2480_CR3","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","volume":"292","author":"H Buchwald","year":"2004","unstructured":"Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724\u20131737","journal-title":"JAMA"},{"key":"2480_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/JOM.0b013e31818def04","volume":"51","author":"NL Kleinman","year":"2009","unstructured":"Kleinman NL, Melkonian A, St B, Rohrbacker N, Lynch WD, Gardner HH (2009) The impact of morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of comorbidities in an employed population. J Occup Environ Med 51:170\u2013179","journal-title":"J Occup Environ Med"},{"key":"2480_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.12968\/bjon.2010.19.5.47083","volume":"19","author":"L Carlos do Rego Furtado","year":"2010","unstructured":"Carlos do Rego Furtado L (2010) Procedure and outcomes of Roux-en-Y gastric bypass. Br J Nurs 19:307\u2013313","journal-title":"Br J Nurs"},{"key":"2480_CR6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ijo.2012.115","volume":"36","author":"F Folli","year":"2012","unstructured":"Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G (2012) Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 36:1373\u20131379","journal-title":"Int J Obes (Lond)"},{"key":"2480_CR7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1381\/096089202321019747","volume":"12","author":"H Buchwald","year":"2002","unstructured":"Buchwald H, Buchwald JN (2002) Evolution of operative procedures for the management of morbid obesity 1950\u20132000. Obes Surg 12:705\u2013717","journal-title":"Obes Surg"},{"key":"2480_CR8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0016-5085(85)90211-2","volume":"89","author":"TE Adrian","year":"1985","unstructured":"Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070\u20131077","journal-title":"Gastroenterology"},{"key":"2480_CR9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.2003.tb03176.x","volume":"994","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Bloom SR (2003) The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci 994:162\u2013168","journal-title":"Ann N Y Acad Sci"},{"key":"2480_CR10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","volume":"349","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941\u2013948","journal-title":"N Engl J Med"},{"key":"2480_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/en.2005-0972","volume":"147","author":"CW Roux le","year":"2006","unstructured":"le Roux CW, Batterham RL, Aylwin SJ et al (2006) Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3\u20138","journal-title":"Endocrinology"},{"key":"2480_CR12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(02)00864-5","volume":"31","author":"IR Reid","year":"2002","unstructured":"Reid IR (2002) Relationships among body mass, its components, and bone. Bone 31:547\u2013555","journal-title":"Bone"},{"key":"2480_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2005-1878","volume":"91","author":"M Misra","year":"2006","unstructured":"Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A (2006) Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91:1027\u20131033","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bone.2009.03.668","volume":"45","author":"M Russell","year":"2009","unstructured":"Russell M, Stark J, Nayak S, Miller KK, Herzog DB, Klibanski A, Misra M (2009) Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 45:104\u2013109","journal-title":"Bone"},{"key":"2480_CR15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI0214588","volume":"109","author":"PA Baldock","year":"2002","unstructured":"Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915\u2013921","journal-title":"J Clin Invest"},{"key":"2480_CR16","doi-asserted-by":"crossref","first-page":"e40038","DOI":"10.1371\/journal.pone.0040038","volume":"7","author":"IP Wong","year":"2012","unstructured":"Wong IP, Driessler F, Khor EC et al (2012) Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 7:e40038","journal-title":"PLoS One"},{"key":"2480_CR17","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2007.08.024","volume":"133","author":"KE Wortley","year":"2007","unstructured":"Wortley KE, Garcia K, Okamoto H et al (2007) Peptide YY regulates bone turnover in rodents. Gastroenterology 133:1534\u20131543","journal-title":"Gastroenterology"},{"key":"2480_CR18","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00125-012-2556-7","volume":"55","author":"C Dirksen","year":"2012","unstructured":"Dirksen C, Jorgensen NB, Bojsen-Moller KN, Jacobsen SH, Hansen DL, Worm D, Holst JJ, Madsbad S (2012) Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 55:1890\u20131901","journal-title":"Diabetologia"},{"key":"2480_CR19","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","volume":"88","author":"T Vilsboll","year":"2003","unstructured":"Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG, Holst JJ (2003) Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88:2706\u20132713","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR20","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1210\/me.2005-0187","volume":"20","author":"K Tsukiyama","year":"2006","unstructured":"Tsukiyama K, Yamada Y, Yamada C et al (2006) Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 20:1644\u20131651","journal-title":"Mol Endocrinol"},{"key":"2480_CR21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","volume":"141","author":"RJ Bollag","year":"2000","unstructured":"Bollag RJ, Zhong Q, Phillips P et al (2000) Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141:1228\u20131235","journal-title":"Endocrinology"},{"key":"2480_CR22","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.1152\/ajpendo.00364.2006","volume":"292","author":"Q Zhong","year":"2007","unstructured":"Zhong Q, Itokawa T, Sridhar S et al (2007) Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 292:E543\u2013E548","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2480_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0303-7207(01)00405-1","volume":"177","author":"RJ Bollag","year":"2001","unstructured":"Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM (2001) Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177:35\u201341","journal-title":"Mol Cell Endocrinol"},{"key":"2480_CR24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bone.2005.06.021","volume":"37","author":"D Xie","year":"2005","unstructured":"Xie D, Cheng H, Hamrick M et al (2005) Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37:759\u2013769","journal-title":"Bone"},{"key":"2480_CR25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bone.2009.11.014","volume":"46","author":"MH Wojcik","year":"2010","unstructured":"Wojcik MH, Meenaghan E, Lawson EA, Misra M, Klibanski A, Miller KK (2010) Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 46:796\u2013800","journal-title":"Bone"},{"key":"2480_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11695-010-0305-x","volume":"21","author":"RS Rao","year":"2011","unstructured":"Rao RS, Kini S (2011) GIP and bariatric surgery. Obes Surg 21:244\u2013252","journal-title":"Obes Surg"},{"key":"2480_CR27","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","volume":"141","author":"Y Date","year":"2000","unstructured":"Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255\u20134261","journal-title":"Endocrinology"},{"key":"2480_CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-0115(98)00101-3","volume":"78","author":"D Lehto-Axtelius","year":"1998","unstructured":"Lehto-Axtelius D, Stenstrom M, Johnell O (1998) Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat. Regul Pept 78:41\u201350","journal-title":"Regul Pept"},{"key":"2480_CR29","first-page":"55","volume":"19","author":"C Ohlsson","year":"1998","unstructured":"Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55\u201379","journal-title":"Endocr Rev"},{"key":"2480_CR30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1359\/JBMR.041237","volume":"20","author":"N Fukushima","year":"2005","unstructured":"Fukushima N, Hanada R, Teranishi H et al (2005) Ghrelin directly regulates bone formation. J Bone Miner Res 20:790\u2013798","journal-title":"J Bone Miner Res"},{"key":"2480_CR31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1113\/expphysiol.2007.041962","volume":"93","author":"F Deng","year":"2008","unstructured":"Deng F, Ling J, Ma J, Liu C, Zhang W (2008) Stimulation of intramembranous bone repair in rats by ghrelin. Exp Physiol 93:872\u2013879","journal-title":"Exp Physiol"},{"key":"2480_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.1.05837","volume":"184","author":"G Maccarinelli","year":"2005","unstructured":"Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D (2005) Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249\u2013256","journal-title":"J Endocrinol"},{"key":"2480_CR33","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1210\/en.2012-1277","volume":"153","author":"M Velde van der","year":"2012","unstructured":"van der Velde M, van der Eerden BC, Sun Y, Almering JM, van der Lely AJ, Delhanty PJ, Smith RG, van Leeuwen JP (2012) An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 153:3593\u20133602","journal-title":"Endocrinology"},{"key":"2480_CR34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","volume":"346","author":"DE Cummings","year":"2002","unstructured":"Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623\u20131630","journal-title":"N Engl J Med"},{"key":"2480_CR35","doi-asserted-by":"crossref","unstructured":"Pournaras DJ, le Roux CW (2010) Ghrelin and metabolic surgery. Int J Pept 2010:217267. doi: 10.1155\/2010\/217267","DOI":"10.1155\/2010\/217267"},{"key":"2480_CR36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/SLA.0b013e3181663421","volume":"247","author":"WJ Pories","year":"2008","unstructured":"Pories WJ (2008) Ghrelin? Yes, it is spelled correctly. Ann Surg 247:408\u2013410","journal-title":"Ann Surg"},{"key":"2480_CR37","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/jc.2004-2537","volume":"90","author":"CW Roux le","year":"2005","unstructured":"le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA, Theodorou NA, Bloom SR (2005) Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90:4521\u20134524","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/jc.2003-031572","volume":"89","author":"T McLaughlin","year":"2004","unstructured":"McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE (2004) Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89:1630\u20131635","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR39","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","volume":"326","author":"M Gutniak","year":"1992","unstructured":"Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7\u201336)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316\u20131322","journal-title":"N Engl J Med"},{"key":"2480_CR40","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1210\/en.2003-0323","volume":"144","author":"L Farilla","year":"2003","unstructured":"Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149\u20135158","journal-title":"Endocrinology"},{"key":"2480_CR41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","volume":"149","author":"C Yamada","year":"2008","unstructured":"Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N (2008) The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology 149:574\u2013579","journal-title":"Endocrinology"},{"key":"2480_CR42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.22243","volume":"225","author":"B Nuche-Berenguer","year":"2010","unstructured":"Nuche-Berenguer B, Portal-Nunez S, Moreno P, Gonzalez N, Acitores A, Lopez-Herradon A, Esbrit P, Valverde I, Villanueva-Penacarrillo ML (2010) Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor. J Cell Physiol 225:585\u2013592","journal-title":"J Cell Physiol"},{"key":"2480_CR43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","volume":"84","author":"B Nuche-Berenguer","year":"2009","unstructured":"Nuche-Berenguer B, Moreno P, Esbrit P, Dapia S, Caeiro JR, Cancelas J, Haro-Mora JJ, Villanueva-Penacarrillo ML (2009) Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif Tissue Int 84:453\u2013461","journal-title":"Calcif Tissue Int"},{"key":"2480_CR44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1463-1326.2010.01355.x","volume":"13","author":"MC Bunck","year":"2011","unstructured":"Bunck MC, Eliasson B, Corner A, Heine RJ, Shaginian RM, Taskinen MR, Yki-Jarvinen H, Smith U, Diamant M (2011) Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab 13:374\u2013377","journal-title":"Diabetes Obes Metab"},{"key":"2480_CR45","first-page":"E156","volume":"267","author":"TR Pieber","year":"1994","unstructured":"Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT (1994) Direct plasma radioimmunoassay for rat amylin-(1\u201337): concentrations with acquired and genetic obesity. Am J Physiol 267:E156\u2013E164","journal-title":"Am J Physiol"},{"key":"2480_CR46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0196-9781(97)00056-9","volume":"18","author":"I Villa","year":"1997","unstructured":"Villa I, Rubinacci A, Ravasi F, Ferrara AF, Guidobono F (1997) Effects of amylin on human osteoblast-like cells. Peptides 18:537\u2013540","journal-title":"Peptides"},{"key":"2480_CR47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bbrc.1995.1163","volume":"207","author":"J Cornish","year":"1995","unstructured":"Cornish J, Callon KE, Cooper GJ, Reid IR (1995) Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 207:133\u2013139","journal-title":"Biochem Biophys Res Commun"},{"key":"2480_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1113\/expphysiol.1993.sp003679","volume":"78","author":"AS Alam","year":"1993","unstructured":"Alam AS, Moonga BS, Bevis PJ, Huang CL, Zaidi M (1993) Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 78:183\u2013196","journal-title":"Exp Physiol"},{"key":"2480_CR49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S8756-3282(01)00494-X","volume":"29","author":"J Cornish","year":"2001","unstructured":"Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162\u2013168","journal-title":"Bone"},{"key":"2480_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/8756-3282(93)90244-5","volume":"14","author":"P Pietschmann","year":"1993","unstructured":"Pietschmann P, Farsoudi KH, Hoffmann O, Klaushofer K, Horandner H, Peterlik M (1993) Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone 14:167\u2013172","journal-title":"Bone"},{"key":"2480_CR51","first-page":"E694","volume":"275","author":"J Cornish","year":"1998","unstructured":"Cornish J, Callon KE, King AR, Cooper GJ, Reid IR (1998) Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol 275:E694\u2013E699","journal-title":"Am J Physiol"},{"key":"2480_CR52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","volume":"164","author":"R Dacquin","year":"2004","unstructured":"Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509\u2013514","journal-title":"J Cell Biol"},{"key":"2480_CR53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/1043-2760(93)90095-V","volume":"4","author":"M Zaidi","year":"1993","unstructured":"Zaidi M, Shankar VS, Huang CL, Pazianas M, Bloom SR (1993) Amylin in bone conservation current evidence and hypothetical considerations. Trends Endocrinol Metab 4:255\u2013259","journal-title":"Trends Endocrinol Metab"},{"key":"2480_CR54","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.bmc.2012.02.030","volume":"20","author":"R Kowalczyk","year":"2012","unstructured":"Kowalczyk R, Harris PW, Brimble MA, Callon KE, Watson M, Cornish J (2012) Synthesis and evaluation of disulfide bond mimetics of amylin-(1\u20138) as agents to treat osteoporosis. Bioorg Med Chem 20:2661\u20132668","journal-title":"Bioorg Med Chem"},{"key":"2480_CR55","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1210\/en.2009-1332","volume":"151","author":"AC Shin","year":"2010","unstructured":"Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR (2010) Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 151:1588\u20131597","journal-title":"Endocrinology"},{"key":"2480_CR56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","volume":"34","author":"SR Kashyap","year":"2010","unstructured":"Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR (2010) Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 34:462\u2013471","journal-title":"Int J Obes (Lond)"},{"key":"2480_CR57","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","volume":"22","author":"SH Jacobsen","year":"2012","unstructured":"Jacobsen SH, Olesen SC, Dirksen C et al (2012) Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 22:1084\u20131096","journal-title":"Obes Surg"},{"key":"2480_CR58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1753-0407.2009.00064.x","volume":"2","author":"M Bose","year":"2010","unstructured":"Bose M, Teixeira J, Olivan B, Bawa B, Arias S, Machineni S, Pi-Sunyer FX, Scherer PE, Laferrere B (2010) Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2:47\u201355","journal-title":"J Diabetes"},{"key":"2480_CR59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cbf.1668","volume":"28","author":"J Yang","year":"2010","unstructured":"Yang J, Zhang X, Wang W, Liu J (2010) Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells. Cell Biochem Funct 28:334\u2013341","journal-title":"Cell Biochem Funct"},{"key":"2480_CR60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gene.2005.07.016","volume":"361","author":"T Niu","year":"2005","unstructured":"Niu T, Rosen CJ (2005) The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361:38\u201356","journal-title":"Gene"},{"key":"2480_CR61","first-page":"2821","volume":"82","author":"S Dagogo-Jack","year":"1997","unstructured":"Dagogo-Jack S, al-Ali N, Qurttom M (1997) Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 82:2821\u20132825","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S8756-3282(98)00095-7","volume":"23","author":"DM Thomas","year":"1998","unstructured":"Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, Best JD (1998) Insulin receptor expression in primary and cultured osteoclast-like cells. Bone 23:181\u2013186","journal-title":"Bone"},{"key":"2480_CR63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296\u2013308","journal-title":"Cell"},{"key":"2480_CR64","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1210\/en.2008-0111","volume":"149","author":"J Cornish","year":"2008","unstructured":"Cornish J, MacGibbon A, Lin JM et al (2008) Modulation of osteoclastogenesis by fatty acids. Endocrinology 149:5688\u20135695","journal-title":"Endocrinology"},{"key":"2480_CR65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00198-007-0492-z","volume":"19","author":"IR Reid","year":"2008","unstructured":"Reid IR (2008) Relationships between fat and bone. Osteoporos Int 19:595\u2013606","journal-title":"Osteoporos Int"},{"key":"2480_CR66","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","volume":"138","author":"VK Yadav","year":"2009","unstructured":"Yadav VK, Oury F, Suda N et al (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976\u2013989","journal-title":"Cell"},{"key":"2480_CR67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"VK Yadav","year":"2008","unstructured":"Yadav VK, Ryu JH, Suda N et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825\u2013837","journal-title":"Cell"},{"key":"2480_CR68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513\u2013523","journal-title":"Cell"},{"key":"2480_CR69","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"2480_CR70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.090721","volume":"25","author":"UI Modder","year":"2010","unstructured":"Modder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ 3rd, Khosla S (2010) Relation of serum serotonin levels to bone density and structural parameters in women. J Bone Miner Res 25:415\u2013422","journal-title":"J Bone Miner Res"},{"key":"2480_CR71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.euroneuro.2009.05.001","volume":"19","author":"S Schwan","year":"2009","unstructured":"Schwan S, Hallberg P (2009) SSRIs, bone mineral density, and risk of fractures\u2014a review. Eur Neuropsychopharmacol 19:683\u2013692","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 1","key":"2480_CR72","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1007\/s00592-003-0083-1","volume":"40","author":"BJ Strauss","year":"2003","unstructured":"Strauss BJ, Marks SJ, Growcott JP, Stroud DB, Lo CS, Dixon JB, O'Brien PE (2003) Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetol 40(Suppl 1):S266\u2013S269","journal-title":"Acta Diabetol"},{"key":"2480_CR73","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11695-007-9408-4","volume":"18","author":"M DiGiorgi","year":"2008","unstructured":"DiGiorgi M, Daud A, Inabnet WB, Schrope B, Urban-Skuro M, Restuccia N, Bessler M (2008) Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg 18:1144\u20131148","journal-title":"Obes Surg"},{"key":"2480_CR74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/oby.2007.639","volume":"15","author":"JB Dixon","year":"2007","unstructured":"Dixon JB, Strauss BJ, Laurie C, O'Brien PE (2007) Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring) 15:1187\u20131198","journal-title":"Obesity (Silver Spring)"},{"key":"2480_CR75","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.metabol.2004.01.015","volume":"53","author":"MA Mach von","year":"2004","unstructured":"von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U (2004) Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 53:918\u2013921","journal-title":"Metabolism"},{"key":"2480_CR76","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jc.2003-031756","volume":"89","author":"PS Coates","year":"2004","unstructured":"Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061\u20131065","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR77","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/oby.2006.226","volume":"14","author":"CS Riedt","year":"2006","unstructured":"Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA (2006) True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 14:1940\u20131948","journal-title":"Obesity (Silver Spring)"},{"key":"2480_CR78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2009-0265","volume":"95","author":"C Bruno","year":"2010","unstructured":"Bruno C, Fulford AD, Potts JR, McClintock R, Jones R, Cacucci BM, Gupta CE, Peacock M, Considine RV (2010) Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 95:159\u2013166","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR79","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1210\/jc.2008-0481","volume":"93","author":"J Fleischer","year":"2008","unstructured":"Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ, Silverberg SJ (2008) The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93:3735\u20133740","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR80","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1381\/0960892041975505","volume":"14","author":"LJ El-Kadre","year":"2004","unstructured":"El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, Tinoco RC (2004) Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg 14:1062\u20131066","journal-title":"Obes Surg"},{"key":"2480_CR81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1381\/096089292765559936","volume":"2","author":"MT Ott","year":"1992","unstructured":"Ott MT, Fanti P, Malluche HH, Ryo UY, Whaley FS, Strodel WE, Colacchi TA (1992) Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 2:341\u2013348","journal-title":"Obes Surg"},{"key":"2480_CR82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/oby.2004.7","volume":"12","author":"LR Goode","year":"2004","unstructured":"Goode LR, Brolin RE, Chowdhury HA, Shapses SA (2004) Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 12:40\u201347","journal-title":"Obes Res"},{"key":"2480_CR83","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s11695-009-9890-y","volume":"19","author":"JP Valderas","year":"2009","unstructured":"Valderas JP, Velasco S, Solari S, Liberona Y, Viviani P, Maiz A, Escalona A, Gonzalez G (2009) Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg 19:1132\u20131138","journal-title":"Obes Surg"},{"key":"2480_CR84","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1359\/jbmr.090307","volume":"24","author":"TJ Beck","year":"2009","unstructured":"Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z (2009) Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res 24:1369\u20131379","journal-title":"J Bone Miner Res"},{"key":"2480_CR85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11695-008-9529-4","volume":"19","author":"JM Gomez","year":"2009","unstructured":"Gomez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, Elio I, Gallart L, Vendrell J (2009) Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 19:345\u2013350","journal-title":"Obes Surg"},{"key":"2480_CR86","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11695-010-0338-1","volume":"21","author":"N Vilarrasa","year":"2011","unstructured":"Vilarrasa N, San Jose P, Garcia I, Gomez-Vaquero C, Miras PM, de Gordejuela AG, Masdevall C, Pujol J, Soler J, Gomez JM (2011) Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg 21:465\u2013472","journal-title":"Obes Surg"},{"key":"2480_CR87","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11695-009-9843-5","volume":"19","author":"N Vilarrasa","year":"2009","unstructured":"Vilarrasa N, Gomez JM, Elio I et al (2009) Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 19:860\u2013866","journal-title":"Obes Surg"},{"key":"2480_CR88","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11695-012-0687-z","volume":"22","author":"DS Casagrande","year":"2012","unstructured":"Casagrande DS, Repetto G, Mottin CC, Shah J, Pietrobon R, Worni M, Schaan BD (2012) Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg 22:1287\u20131292","journal-title":"Obes Surg"},{"key":"2480_CR89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11695-008-9638-0","volume":"19","author":"F Carrasco","year":"2009","unstructured":"Carrasco F, Ruz M, Rojas P et al (2009) Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 19:41\u201346","journal-title":"Obes Surg"},{"key":"2480_CR90","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s11695-008-9653-1","volume":"18","author":"T Mahdy","year":"2008","unstructured":"Mahdy T, Atia S, Farid M, Adulatif A (2008) Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg 18:1526\u20131531","journal-title":"Obes Surg"},{"key":"2480_CR91","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jbmr.506","volume":"27","author":"EW Yu","year":"2012","unstructured":"Yu EW, Thomas BJ, Brown JK, Finkelstein JS (2012) Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res 27:119\u2013124","journal-title":"J Bone Miner Res"},{"key":"2480_CR92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-6009(90)90101-K","volume":"9","author":"TN Hangartner","year":"1990","unstructured":"Hangartner TN, Johnston CC (1990) Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 9:71\u201381","journal-title":"Bone Miner"},{"key":"2480_CR93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1259\/bjr.72.859.10624323","volume":"72","author":"P Tothill","year":"1999","unstructured":"Tothill P, Laskey MA, Orphanidou CI, van Wijk M (1999) Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol 72:661\u2013669","journal-title":"Br J Radiol"},{"key":"2480_CR94","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s004210050204","volume":"75","author":"OR Madsen","year":"1997","unstructured":"Madsen OR, Jensen JE, Sorensen OH (1997) Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition. Eur J Appl Physiol Occup Physiol 75:554\u2013558","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"2480_CR95","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bone.2007.02.022","volume":"41","author":"HH Bolotin","year":"2007","unstructured":"Bolotin HH (2007) DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 41:138\u2013154","journal-title":"Bone"},{"key":"2480_CR96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.apnr.2007.03.004","volume":"22","author":"A Berarducci","year":"2009","unstructured":"Berarducci A, Haines K, Murr MM (2009) Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res 22:35\u201341","journal-title":"Appl Nurs Res"},{"key":"2480_CR97","doi-asserted-by":"crossref","first-page":"e5085","DOI":"10.1136\/bmj.e5085","volume":"345","author":"A Lalmohamed","year":"2012","unstructured":"Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC (2012) Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 345:e5085","journal-title":"BMJ"},{"key":"2480_CR98","first-page":"354","volume":"6","author":"AG Robling","year":"2006","unstructured":"Robling AG, Bellido T, Turner CH (2006) Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 6:354","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2480_CR99","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"LF Bonewald","year":"2008","unstructured":"Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606\u2013615","journal-title":"Bone"},{"key":"2480_CR100","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/jbmr.1560","volume":"27","author":"R Armamento-Villareal","year":"2012","unstructured":"Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT (2012) Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 27:1215\u20131221","journal-title":"J Bone Miner Res"},{"key":"2480_CR101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI111971","volume":"76","author":"NH Bell","year":"1985","unstructured":"Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370\u2013373","journal-title":"J Clin Invest"},{"key":"2480_CR102","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/ajcn\/34.11.2359","volume":"34","author":"JE Compston","year":"1981","unstructured":"Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359\u20132363","journal-title":"Am J Clin Nutr"},{"key":"2480_CR103","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1381\/0960892053576758","volume":"15","author":"J Ybarra","year":"2005","unstructured":"Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A (2005) Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 15:330\u2013335","journal-title":"Obes Surg"},{"key":"2480_CR104","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1381\/096089205774859182","volume":"15","author":"J Sanchez-Hernandez","year":"2005","unstructured":"Sanchez-Hernandez J, Ybarra J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A (2005) Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 15:1389\u20131395","journal-title":"Obes Surg"},{"key":"2480_CR105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.sla.0000216773.47825.c1","volume":"243","author":"JM Johnson","year":"2006","unstructured":"Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM (2006) The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 243:701\u2013704, discussion 704\u2013705","journal-title":"Ann Surg"},{"key":"2480_CR106","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jcb.10338","volume":"88","author":"MF Holick","year":"2003","unstructured":"Holick MF (2003) Vitamin D: A millenium perspective. J Cell Biochem 88:296\u2013307","journal-title":"J Cell Biochem"},{"key":"2480_CR107","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR108","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00198-010-1285-3","volume":"21","author":"B Dawson-Hughes","year":"2010","unstructured":"Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151\u20131154","journal-title":"Osteoporos Int"},{"key":"2480_CR109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1381\/0960892053268264","volume":"15","author":"RD Bloomberg","year":"2005","unstructured":"Bloomberg RD, Fleishman A, Nalle JE, Herron DM, Kini S (2005) Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 15:145\u2013154","journal-title":"Obes Surg"},{"key":"2480_CR110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bone.2005.08.018","volume":"38","author":"MJ Bolland","year":"2006","unstructured":"Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR (2006) Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 38:317\u2013321","journal-title":"Bone"},{"key":"2480_CR111","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1210\/jc.2005-0216","volume":"90","author":"MB Snijder","year":"2005","unstructured":"Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90:4119\u20134123","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR112","first-page":"177","volume":"32","author":"Z Ostrowska","year":"1998","unstructured":"Ostrowska Z, Zwirska-Korczala K, Buntner B, Pardela M, Drozdz M (1998) Assessment of bone metabolism in obese women. Endocr Regul 32:177\u2013181","journal-title":"Endocr Regul"},{"key":"2480_CR113","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/eje.0.1510167","volume":"151","author":"E Kamycheva","year":"2004","unstructured":"Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 151:167\u2013172","journal-title":"Eur J Endocrinol"},{"key":"2480_CR114","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1381\/0960892042386959","volume":"14","author":"F Diniz Mde","year":"2004","unstructured":"Diniz Mde F, Diniz MT, Sanches SR, Salgado PP, Valadao MM, Araujo FC, Martins DS, Rocha AL (2004) Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg 14:1222\u20131226","journal-title":"Obes Surg"},{"key":"2480_CR115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00464-007-9228-6","volume":"21","author":"Y Youssef","year":"2007","unstructured":"Youssef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A (2007) Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 21:1393\u20131396","journal-title":"Surg Endosc"},{"key":"2480_CR116","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00198-006-0084-3","volume":"17","author":"O Sahota","year":"2006","unstructured":"Sahota O, Mundey MK, San P, Godber IM, Hosking DJ (2006) Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17:1013\u20131021","journal-title":"Osteoporos Int"},{"key":"2480_CR117","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s11695-008-9536-5","volume":"19","author":"HE Johansson","year":"2009","unstructured":"Johansson HE, Zethelius B, Ohrvall M, Sundbom M, Haenni A (2009) Serum magnesium status after gastric bypass surgery in obesity. Obes Surg 19:1250\u20131255","journal-title":"Obes Surg"},{"key":"2480_CR118","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1359\/JBMR.040204","volume":"19","author":"R Rizzoli","year":"2004","unstructured":"Rizzoli R, Bonjour JP (2004) Dietary protein and bone health. J Bone Miner Res 19:527\u2013531","journal-title":"J Bone Miner Res"},{"key":"2480_CR119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jtemb.2012.03.017","volume":"26","author":"J Aaseth","year":"2012","unstructured":"Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements\u2014an overview. J Trace Elem Med Biol 26:149\u2013152","journal-title":"J Trace Elem Med Biol"},{"key":"2480_CR120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1359\/jbmr.070813","volume":"23","author":"LJ Zhao","year":"2008","unstructured":"Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17\u201329","journal-title":"J Bone Miner Res"},{"key":"2480_CR121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","volume":"310","author":"CB Confavreux","year":"2009","unstructured":"Confavreux CB, Levine RL, Karsenty G (2009) A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 310:21\u201329","journal-title":"Mol Cell Endocrinol"},{"key":"2480_CR122","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tem.2008.02.006","volume":"19","author":"NK Lee","year":"2008","unstructured":"Lee NK, Karsenty G (2008) Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19:161\u2013166","journal-title":"Trends Endocrinol Metab"},{"key":"2480_CR123","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10408369991239259","volume":"36","author":"J Himms-Hagen","year":"1999","unstructured":"Himms-Hagen J (1999) Physiological roles of the leptin endocrine system: differences between mice and humans. Crit Rev Clin Lab Sci 36:575\u2013655","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2480_CR124","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","volume":"334","author":"RV Considine","year":"1996","unstructured":"Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292\u2013295","journal-title":"N Engl J Med"},{"key":"2480_CR125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","volume":"175","author":"J Cornish","year":"2002","unstructured":"Cornish J, Callon KE, Bava U et al (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405\u2013415","journal-title":"J Endocrinol"},{"key":"2480_CR126","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","volume":"85","author":"JO Gordeladze","year":"2002","unstructured":"Gordeladze JO, Drevon CA, Syversen U, Reseland JE (2002) Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825\u2013836","journal-title":"J Cell Biochem"},{"key":"2480_CR127","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.coph.2004.01.009","volume":"4","author":"T Thomas","year":"2004","unstructured":"Thomas T (2004) The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 4:295\u2013300","journal-title":"Curr Opin Pharmacol"},{"key":"2480_CR128","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1359\/jbmr.2001.16.8.1426","volume":"16","author":"JE Reseland","year":"2001","unstructured":"Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA (2001) Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426\u20131433","journal-title":"J Bone Miner Res"},{"key":"2480_CR129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","volume":"17","author":"WR Holloway","year":"2002","unstructured":"Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17:200\u2013209","journal-title":"J Bone Miner Res"},{"key":"2480_CR130","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/endo.142.8.8346","volume":"142","author":"B Burguera","year":"2001","unstructured":"Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT (2001) Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546\u20133553","journal-title":"Endocrinology"},{"key":"2480_CR131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-0115(00)00152-X","volume":"92","author":"CM Steppan","year":"2000","unstructured":"Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG (2000) Leptin is a potent stimulator of bone growth in ob\/ob mice. Regul Pept 92:73\u201378","journal-title":"Regul Pept"},{"key":"2480_CR132","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197\u2013207","journal-title":"Cell"},{"key":"2480_CR133","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305\u2013317","journal-title":"Cell"},{"key":"2480_CR134","doi-asserted-by":"crossref","first-page":"954","DOI":"10.18632\/aging.100100","volume":"1","author":"VK Yadav","year":"2009","unstructured":"Yadav VK, Karsenty G (2009) Leptin-dependent co-regulation of bone and energy metabolism. Aging (Albany NY) 1:954\u2013956","journal-title":"Aging (Albany NY)"},{"key":"2480_CR135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2006.10.008","volume":"4","author":"G Karsenty","year":"2006","unstructured":"Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341\u2013348","journal-title":"Cell Metab"},{"key":"2480_CR136","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/jbmr.060206","volume":"21","author":"LA Weiss","year":"2006","unstructured":"Weiss LA, Barrett-Connor E, von Muhlen D, Clark P (2006) Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study. J Bone Miner Res 21:758\u2013764","journal-title":"J Bone Miner Res"},{"key":"2480_CR137","first-page":"1884","volume":"86","author":"JA Pasco","year":"2001","unstructured":"Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC (2001) Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86:1884\u20131887","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR138","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/jcem.87.3.8313","volume":"87","author":"H Blain","year":"2002","unstructured":"Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N, Doucet B, Jeandel C (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87:1030\u20131035","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR139","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2265.2003.01808.x","volume":"59","author":"E Zoico","year":"2003","unstructured":"Zoico E, Zamboni M, Adami S, Vettor R, Mazzali G, Tosoni P, Bissoli L, Bosello O (2003) Relationship between leptin levels and bone mineral density in the elderly. Clin Endocrinol (Oxf) 59:97\u2013103","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2480_CR140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S8756-3282(00)00408-7","volume":"28","author":"G Martini","year":"2001","unstructured":"Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113\u2013117","journal-title":"Bone"},{"key":"2480_CR141","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s002239900557","volume":"63","author":"A Goulding","year":"1998","unstructured":"Goulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456\u2013458","journal-title":"Calcif Tissue Int"},{"key":"2480_CR142","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, Halaas J, Ravussin E et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155\u20131161","journal-title":"Nat Med"},{"key":"2480_CR143","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/eje.1.01978","volume":"153","author":"PW Peake","year":"2005","unstructured":"Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA (2005) The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 153:409\u2013417","journal-title":"Eur J Endocrinol"},{"key":"2480_CR144","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","volume":"35","author":"HS Berner","year":"2004","unstructured":"Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842\u2013849","journal-title":"Bone"},{"key":"2480_CR145","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2008-1639","volume":"150","author":"GA Williams","year":"2009","unstructured":"Williams GA, Wang Y, Callon KE et al (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603\u20133610","journal-title":"Endocrinology"},{"key":"2480_CR146","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1210\/jc.2011-0047","volume":"96","author":"E Biver","year":"2011","unstructured":"Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2703\u20132713","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR147","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","volume":"331","author":"K Oshima","year":"2005","unstructured":"Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520\u2013526","journal-title":"Biochem Biophys Res Commun"},{"key":"2480_CR148","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexcr.2005.05.021","volume":"309","author":"XH Luo","year":"2005","unstructured":"Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99\u2013109","journal-title":"Exp Cell Res"},{"key":"2480_CR149","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1574-695X.2006.00164.x","volume":"49","author":"N Yamaguchi","year":"2007","unstructured":"Yamaguchi N, Kukita T, Li YJ, Martinez Argueta JG, Saito T, Hanazawa S, Yamashita Y (2007) Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol 49:28\u201334","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2480_CR150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.20890","volume":"99","author":"Y Shinoda","year":"2006","unstructured":"Shinoda Y, Yamaguchi M, Ogata N et al (2006) Regulation of bone formation by adiponectin through autocrine\/paracrine and endocrine pathways. J Cell Biochem 99:196\u2013208","journal-title":"J Cell Biochem"},{"key":"2480_CR151","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279\u2013302","journal-title":"Endocr Rev"},{"key":"2480_CR152","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.genm.2011.05.007","volume":"8","author":"SR Rao","year":"2011","unstructured":"Rao SR, Kini S, Tamler R (2011) Sex hormones and bariatric surgery in men. Gend Med 8:300\u2013311","journal-title":"Gend Med"},{"key":"2480_CR153","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-11-0452","volume":"213","author":"G Karsenty","year":"2012","unstructured":"Karsenty G (2012) The mutual dependence between bone and gonads. J Endocrinol 213:107\u2013114","journal-title":"J Endocrinol"},{"key":"2480_CR154","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1381\/096089203765887705","volume":"13","author":"E Guney","year":"2003","unstructured":"Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T (2003) Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 13:383\u2013388","journal-title":"Obes Surg"},{"key":"2480_CR155","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/jc.2008-1598","volume":"94","author":"A Hammoud","year":"2009","unstructured":"Hammoud A, Gibson M, Hunt SC, Adams TD, Carrell DT, Kolotkin RL, Meikle AW (2009) Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 94:1329\u20131332","journal-title":"J Clin Endocrinol Metab"},{"key":"2480_CR156","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1172\/JCI117049","volume":"93","author":"N Mauras","year":"1994","unstructured":"Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL (1994) Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J Clin Invest 93:1014\u20131019","journal-title":"J Clin Invest"},{"key":"2480_CR157","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3181\/00379727-200-43467","volume":"200","author":"WG Hope","year":"1992","unstructured":"Hope WG, Ibarra MJ, Thomas ML (1992) Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat. Proc Soc Exp Biol Med 200:536\u2013541","journal-title":"Proc Soc Exp Biol Med"},{"key":"2480_CR158","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2004.05.001","volume":"222","author":"D Couchourel","year":"2004","unstructured":"Couchourel D, Leclerc M, Filep J, Brunette MG (2004) Testosterone enhances calcium reabsorption by the kidney. Mol Cell Endocrinol 222:71\u201381","journal-title":"Mol Cell Endocrinol"},{"key":"2480_CR159","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2010.07.001","volume":"503","author":"V Carnevale","year":"2010","unstructured":"Carnevale V, Romagnoli E, Cipriani C, Del Fiacco R, Piemonte S, Pepe J, Scillitani A, Minisola S (2010) Sex hormones and bone health in males. Arch Biochem Biophys 503:110\u2013117","journal-title":"Arch Biochem Biophys"},{"key":"2480_CR160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.fertnstert.2008.08.026","volume":"90","author":"AO Hammoud","year":"2008","unstructured":"Hammoud AO, Gibson M, Peterson CM, Meikle AW, Carrell DT (2008) Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril 90:897\u2013904","journal-title":"Fertil Steril"},{"key":"2480_CR161","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.fertnstert.2007.10.011","volume":"90","author":"AO Hammoud","year":"2008","unstructured":"Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW (2008) Male obesity and alteration in sperm parameters. Fertil Steril 90:2222\u20132225","journal-title":"Fertil Steril"},{"key":"2480_CR162","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/jbmr.060110","volume":"21","author":"D Mellstrom","year":"2006","unstructured":"Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529\u2013535","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2480-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2480-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T07:57:28Z","timestamp":1563868648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2480-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2480-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}